Trials / Sponsors / Peng Wang, MD PhD
Peng Wang, MD PhD
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Metastatic Hormone-Sensitive Prostate Cancer | Phase 1 / Phase 2 | 2018-02-14 |
| Completed | Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors Solid Tumor | Phase 1 | 2017-08-08 |
| Completed | HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors Solid Tumor | Phase 1 | 2015-07-01 |